Learning Objectives: -Accurately assess patient and clinical risk factors in the diagnosis and prognosis of LR-MDS to guide treatment decisions that relieve the burden of symptomatic anemia -Evaluate risk factors and stratification criteria for MDS and associated anemia to determine prognosis and treatment strategies -Utilize collaborative approaches to enhance health outcomes for individuals with symptomatic anemia -Appropriately evaluate the efficacy and safety of the newest game-changing therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS -Develop long-term, individualized care plans for anemia management for patients with LR-MDS
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://learn.mlieducation.org/courses
- Start Date: 2024-05-31 05:00:00
- End Date: 2024-05-31 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bristol Myers Squibb - Amount: 24162.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine, Medical Oncology